Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremia

American Journal of Kidney Diseases

Volumn 28, Issue 6, 1996, Pages 924-930

  Avram, Morrell Michael ^a   Sreedhara, Rajanna ^a   Avram, David K ^a   Muchnick, Robert A ^a   Fein, Paul ^a  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

Author keywords

hemodialysis; intact PTH; Mortality; peritoneal dialysis; survival

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CALCIUM; CHOLESTEROL; CREATININE; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGE; AGED; CONFERENCE PAPER; CREATININE BLOOD LEVEL; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERITONEAL DIALYSIS; SURVIVAL; UREMIA;

EID: 0029800539     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90396-0     Document Type: Conference Paper

References (53)

1. Anonymous: Morbidity and mortality of renal dialysis: An NIH consensus conference statement. Ann Intern Med 121:62-70, 1995
2. United States Renal Data System USRDS 1995 Annual Data Report. Bethesda, MD, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995
3. Lowrie EG, Lew NL: Death risk in hemodialysis: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
4. Lowrie EG, Lew NL, Huang WH: Race and diabetes as death risk predictors in hemodialysis patients. Kidney Int 42:S22-S31, 1992 (suppl)
5. Kopple JD: Effect of nutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis 24:1002-1009, 1994
6. Churchill DM, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H, McKenzie JK, Muirhead N, Parfrey PS, Posen GA, Slaughter D, Ulah RA, Werb R: Canadian hemodialysis morbidity study. Am J Kidney Dis 3:214-234, 1992
7. Goldwasser P, Mittman N, Antignani A, Burrell D, Michel MA, Collier J, Avram MM: Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 3:1613-1622, 1993
8. Avram MM, Goldwasser P, Erroa M, Fein PA: Predictors of survival in continuous ambulatory peritoneal dialysis patients: The importance of prealbumin and other nutritional and metabolic markers. Am J Kidney Dis 23:91-98, 1994
9. Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein PA: Markers for survival in dialysis: A seven year prospective study. Am J Kidney Dis 26:209-219, 1995
10. Llach F, Massry SG: On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. J Clin Endocrinol Metab 61:601-606, 1985
11. Delmez JA, Slatopolsky E: Hyperphosphatemia: Its consequences and treatment in chronic renal failure. Am J Kidney Dis 19:303-317, 1992
12. Slatopolsky E, Caglar S, Pennell JP, Taggart D, Canterbury JM, Reiss E, Bricker NS: On the pathogenesis of hyperparathyroidism in chronic experimental insufficiency in the dog. J Clin Invest 50:492-499, 1971
13. Bricker NS: Trade off hypothesis. N Engl J Med 286:1093-1095, 1972
14. Milliner DS, Zinmeister AR, Lieberman E, Landing B: Soft tissue calcification in pédiatrie patients with end-stage renal disease. Kidney Int 38:931-936, 1990
15. Slatopolsky E, Bricker NS: The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in renal disease. Kidney Int 4:141-148, 1973
16. Portale AA, Booth BE, Halloran BP, Morris RC Jr: Effect of dietary phosphate on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 73:1580-1589, 1984
17. Delmez JA, Slatopolsky E: Recent advances in the pathogenesis and therapy of urémie secondary hyperparathyroidism. J Clin Endocrinol Metab 72:735-739, 1991
18. Combe C, Aparicio M: Phosphorus and protein restriction and parathyroid function in chronic renal failure. Kidney Int 46:1381-1386, 1994
19. Harris DC, Falk SA, Conger JD, Hammond WS, Schrier RW: Phosphate restriction reduces proteinuria of the uninephrectomized diabetic rat. Am J Kidney Dis 11:489-498, 1988
20. Ibels LS, Alfrey AC, Haut L, Hubbcr WE: Preservation of function in experimental renal disease by dietary restriction of phosphate. N Engl J Med 298:122-126, 1978
21. Barsotti G, Giannoni A, Morelli E, Lazzeri M, Vlamis I, Baldi R, Giovanetti S: The decline in renal function slowed by very low phosphorus intake in chronic renal patients following a low nitrogen diet. Clin Nephrol 21:54-59, 1984
22. Bourgoigne JJ: Progression of renal disease: Current concepts and therapeutic approaches. Kidney Int 41:S61-S65, 1992 (suppl)
23. Mitch WE: Dietary manipulation and progression of chronic renal failure. Child Nephrol Ural 11:134-139, 1991
24. Ahmed FE: Effect of diet on progression of chronic renal disease. J Am Diet Assoc 91:1266-1270, 1991
25. Massry SG, Popovtzer MM, Coburn JW, Makoff DL, Maxwell MH, Kleeman CR: Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. N Engl J Med 279:697-700, 1968
26. Guisado R, Arieff AI, Massry SG: Changes in the electroencephalogram in acute uremia: Effects of parathyroid hormone and brain electrolytes. J Clin Invest 55:738-745, 1975
27. Massry SG: Is parathyroid hormone a uremic toxin? Nephron 19:125-130, 1977
28. Cooper JD, Lazarowitz VC, Arieff AI: Neurodiagnostic abnormalities in patients with acute renal failure evidence for neurotoxicity of parathyroid hormone. J Clin Invest 61:1448-1455, 1978
29. Avram MM, lancu M, Morrow P, Feinfeld D, Huatuco A: Uremic syndrome in man: New evidence for parathormone as a multisystem neurotoxin. Clin Nephrol 11:59-62, 1979
30. Klahr S, Hruska K, Martin K: Effects of parathyroid hormone on glucose production by the liver, in Avram MM (ed): Parathyroid Hormone in Kidney Failure. New York, NY, Karger, 1980, pp 129-137
31. Adler AJ, Berlyne GM: Tissue calcium and magnesium levels in skin and brain in the chronically uremic rat, in Avram MM (ed): Parathyroid Hormone in Kidney Failure. New York, NY, Karger, 1980, pp 67-72
32. Ichikawa I, Brenner BM: Effects of parathyroid hormone on glomerular function, in Avram MM (ed): Parathyroid Hormone in Kidney Failure. New York, NY, Karger, 1980, pp 38-45
33. Kopple JD, Cianciaruso B, Massry SG: Does parathyroid hormone cause protein wasting? in Avram MM (ed): Parathyroid Hormone in Kidney Failure. New York, NY, Karger, 1980, pp 138-148
34. Heuck CC, Ritz E: Does parathyroid hormone play a role in lipid metabolism? in Avram MM (ed): Parathyroid Hormone in Kidney Failure. New York, NY, Karger, 1980, pp 118-128
35. Walser M, Mitch WE, Collier VU: Calcium and phosphorus in chronic renal failure during nutritional therapy, in Avram MM (ed): Parathyroid Hormone in Kidney Failure. New York, NY, Karger, 1980, pp 92-102
36. Yalow RS: Clinical significance of the heterogeneity of parathyroid hormone, in Avram MM (ed): Parathyroid Hormone in Kidney Failure. New York, NY, Karger, 1980, pp 15-20
37. Avram MM: Lower parathyroid hormone and creatinine in diabetic uremia, in Avram MM (ed): Parathyroid Hormone in Kidney Failure. New York, NY, Karger, 1980, PP4-8
38. Vanholder R, DeSmet R, Hsu C, Vogeleere P, Ringoir S: Uremic toxicity: The middle molecule hypothesis revisited. Semin Nephrol 14:205-218, 1994
39. Avram MM, Feinfeld DA, Huatuco AH: Search for the urémie toxin: Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia. N Engl J Med 298:1000-1003, 1978
40. Ben Hamida F, Ghazali A, Boudzernidj M, Amar M, Moriniere P, Westeel P, Fournier A: Hyperparathyroidism secondary to renal insufficiency: Physiopathology, clinicoradiological aspects and treatment. Ann Endocrinol 55:147-158, 1994
41. Williams PS, Stevens ME, Fass G, Irons L, Bone JM: Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: A prospective, randomized, controlled trial. Q J Med 81:837-855, 1991
42. Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y: Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminium toxicity. Am J Kidney Dis 26:836-844, 1995
43. Torres A, Lorenzo V, Hernandez D, Rodriguez JC, Concepcion MT, Rodriguez AP, Hernandez A, de Bonis E, Darias E, Gonzalez-Posada JM, Losada M, Rufino M, Felsenfeld AJ, Rodriguez M: Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH. Kidney Int 47:1434-1442, 1995
44. Massry SG, Coburn JW, Lee DBN, Jowsey LJ, Kleeman CR: Skeletal resistance to parathyroid hormone in renal failure: Study in 105 human subjects. Ann Intern Med 78:357-364, 1973
45. Standl E: Hyperinsulinemia and atherosclerosis. Clin Invest Med 18:261-266, 1995
46. Mak RH: Insulin secretion and growth failure in uremia. Pediatr Res 38:379-383, 1995
47. Ritz E, Stefanski A, Rambausek M: The role of the parathyroid glands in the urémie syndrome. Am J Kidney Dis 26:808-813, 1995
48. Ndiaye B, Cournot G, Pelissier MA, Debray OW, Lemonnier D: Rat serum osteocalcin concentration is decreased by restriction of energy. J Nutr 125:1283-1290, 1995
49. Licata AA: Acute effects of increased meat protein on urinary electrolytes and cyclic adenosine monophosphate and serum parathyroid hormone. Am J Clin Nutr 34:1779-1784, 1981
50. Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM: Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 6:1386-1391, 1995
51. Bergstrom J: Why are dialysis patients malnourished? Am J Kidney Dis 26:229-241, 1995
52. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM: Amino acid and albumin losses during hemodialysis. Kidney Int 46:830-837, 1994
53. Kopple JD, Hakim RM, Held PJ, Keane WF, King K, Lazarus JM, Parker TF, Teehan BP: Recommendations for reducing the high morbidity and mortality of United States maintenance dialysis patients. Am J Kidney Dis 24:968-973, 1994